Laboratorium for analyse av små molekyler
- Prosjektnummer
- 911622
- Ansvarlig person
- Gunnar Mellgren
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Metabolic and Endocrine, Other
- Forskningsaktivitet
- 4. Detection and Diagnosis
Menopause as a predictor of new-onset asthma: A longitudinal Northern European population study.
J Allergy Clin Immunol 2016 Jan;137(1):50-7.e6. Epub 2015 okt 2
PMID: 26435006
Effect of a pre-exercise hydrocortisone dose on short-term physical performance in female patients with primary adrenal failure.
Eur J Endocrinol 2016 Jan;174(1):97-105. Epub 2015 okt 22
PMID: 26494876
Menopause Is Associated with Accelerated Lung Function Decline.
Am J Respir Crit Care Med 2017 Apr 15;195(8):1058-1065.
PMID: 27907454
Circadian hormone profiles and insulin sensitivity in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy.
Clin Endocrinol (Oxf) 2015 Jul;83(1):28-35. Epub 2015 jan 12
PMID: 25400085
Response of cortisol metabolites in the insulin tolerance test and Synacthen tests.
Physiol Res 2015;64 Suppl 2():S237-46.
PMID: 26680485
Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison's disease: a randomized clinical trial.
J Clin Endocrinol Metab 2014 May;99(5):1665-74. Epub 2014 feb 11
PMID: 24517155
High fish intake may improve the leukocyte function and increase omega-3 fatty acid levels in leukocyte membrane.
Oral presentation. 10th Nordic Nutrition Conference, Reykjavik, Iceland, 3-5 June, 2012.
Øksnes M, Bjørnsdottir S, Isaksson M, Nilsen RM, Carlsen S, Kämpe O, Hulting A-L, Bensing S, Husebye ES, Løvås K.
Poster. Endokrinologisk vintermøte, Trondheim, 6-8 March, 2013.
Continuous subcutaneous hydrocortisone infusion improves Quality of life in Addison’s disease.
Featured poster. ENDO2013, San Francisco, USA, 15-18 June, 2013.
Continous subcutaneous hydrocortisone infusion (CSHI) in Addison’s disease: effects on health related quality of life.
Oral presentation. ENDO2013, San Francisco, USA, 15-18 juni 2013.
G8Way: a flexible program for sample processing and LC-MS/MS method development.
Oral presentation. HNU meeting, Copenhagen, Denmark. 25 September, 2013.
Clinically important isobaric interferences in LC-MS/MS methods for steroid hormones.
WCU Meeting, Vejle Hospital, Denmark, 4 November, 2013.
Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease.
J Clin Endocr Metab: in press.
Glucocorticoid Treatment and Quality of Life in Addison’s disease
- Disputert:
- juni 2014
- Hovedveileder:
- Kristian Løvås
- Rune Johan Ulvik Prosjektdeltaker
- Klaus Meyer Prosjektdeltaker
- Ernst Asbjørn Lien Prosjektdeltaker
- Eystein Sverre Husebye Prosjektdeltaker
- Bjørn Tore Gjertsen Prosjektdeltaker
- Asbjørn Svardal Prosjektdeltaker
- Simon Steinar Hustad Prosjektdeltaker
- Per Magne Ueland Prosjektdeltaker
- Gunnar Mellgren Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest